Carbimazole Tablets BP 10 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Carbimazole Tablets BP 10 mg | Manufacturer
Product image for Carbimazole Tablets BP 10 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Carbimazole |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antithyroid drugs |
| Subcategory | Antithyroid drugs |
| Active Ingredient | Carbimazole |
| Strength | 10 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antithyroid drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Carbimazole Tablets BP 10 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Therapeutic management of indicated clinical conditions as authorized by clinical compendia. 2. Symptom control and maintenance therapy as part of comprehensive patient treatment regimens. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Carbimazole Tablets BP 10 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Carbimazole Tablets BP 10 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Carbimazole Tablets BP 10 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Carbimazole Tablets BP 10 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally as directed by the prescribing physician. Swallow whole with water; adhere strictly to the recommended therapeutic regimen and schedule. | ||||||||||||||||||||||||
| Side Effects | Common: Mild nausea, headache, gastrointestinal discomfort, transient fatigue. Uncommon: Dizziness, dry mouth, mild cutaneous rash, loose stools. Rare: Severe allergic hypersensitivity, acute idiosyncratic reactions. | ||||||||||||||||||||||||
| Warnings and Precautions | Clinical Supervision: Use under qualified medical guidance. Organ Function Monitoring: Perform routine renal and hepatic evaluations during prolonged therapy. Disclose all concurrent medications, allergies, and medical history prior to treatment. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Carbimazole or tablet inactive ingredients. 2. Severe organ decompensation or acute metabolic crises. 3. Uncontrolled acute systemic disorders without specialized medical monitoring. | ||||||||||||||||||||||||
| Drug Interactions | 1. Concomitant prescription pharmaceuticals: Potential pharmacokinetic and pharmacodynamic interactions requiring physician review. 2. Central depressants or alcohol: May accentuate adverse neurological or sedative symptoms. 3. Over-the-counter supplements: Consult a clinician before combination. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Carbimazole Tablets BP 10 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Carbimazole Tablets BP 10 mg? | The source specification is BP; confirm the required standard before contracting. |
| What quality tests are applicable for Carbimazole Tablets BP 10 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Carbimazole Tablets BP 10 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Carbimazole Tablets BP 10 mg? | Provide forecast volume, target market, strength and packaging requirements. |
